Yale SPORE in Lung Cancer News
While the study is a signal that time of day for immunotherapy infusion is worth investigating further, Roy Herbst, the deputy director of the Yale Cancer Center, said he’s not going to change practice based on the trial. “It’s intriguing. This is maybe a wake-up call to look at it more," Herbst said.
- January 28, 2026
A dozen awards honored 15 people at January's Yale Cancer Center Annual Awards for work in 2025.
- January 28, 2026Source: Time
Medical oncologist Dr. Roy S. Herbst explains the importance of cancer screenings
- January 26, 2026
Researchers uncovered potential treatment strategies for stromal sarcoma of the uterus by establishing a more detailed understanding of the aggressive tumors at the molecular level.
- January 23, 2026Source: New York Times (with Yale's Dr. Roy Herbst)
Nytimes article about antibodies that can defeat cancer -- could they become a treatment?
- January 05, 2026Source: New England Journal of Medicine (Yale's Dr. Roy Herbst)
Combination chemotherapy has long been a mainstay of cancer treatment, although early mechanism-based therapies showed little promise. More than 50 years later, this foundational principle — in which biologic rationale is used to guide the choice of treatment combinations — is being applied to the leading cause of cancer-related deaths: lung cancer. Today, genomic profiling, targeted agents, and strategies informed by resistance mechanisms are reshaping care for epithelial growth factor receptor (EGFR)–mutated non–small-cell lung cancer (NSCLC).
- December 22, 2025
Veronica Chiang, MD, professor of neurosurgery, is currently leading several clinical trials seeking to improve treatments for brain metastases, or cancers that has spread to the brain). She recently sat down for an interview about this important work.
- December 22, 2025Source: CNN
Legendary singer songwriter Barry Manilow reveals that he's been diagnosed with lung cancer. We'll ask a lung cancer specialist what sort of treatment may lie ahead.
- December 16, 2025
Members of the Center for Breast Cancer and the Hematology Program at Yale Cancer Center and Smilow Cancer Hospital recently presented their latest groundbreaking research on two national stages. First at the annual American Society of Hematology (ASH) meeting, followed by the annual San Antonio Breast Cancer Symposium (SABCS).
- December 13, 2025
Members of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center attended the 48th annual San Antonio Breast Cancer Symposium (SABCS), from December 9-12, 2025.